Rab 39B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Rab 39B protein. Rab 39B is a member of the Rab family of small GTPases, which are critical regulators of intracellular vesicle trafficking. These proteins switch between an active GTP-bound form and an inactive GDP-bound form, playing a key role in processes such as endocytosis, exocytosis, and intracellular transport. Rab 39B is particularly involved in the regulation of vesicle trafficking between the Golgi apparatus and endosomes, as well as the transport of specific cargo proteins, such as those involved in maintaining cellular homeostasis and signaling pathways. By inhibiting Rab 39B activity, these compounds can modulate vesicular transport and protein sorting within cells, making them useful for studying various cellular processes.
Chemically, Rab 39B inhibitors are diverse in structure, encompassing a range of small molecules that can bind to Rab 39B with high specificity. They work by interfering with the GTPase's ability to bind and hydrolyze GTP, disrupting its normal function and downstream signaling. This interference can lead to alterations in vesicle formation, trafficking, and cargo delivery, which in turn can impact a variety of cellular mechanisms. These inhibitors are valuable in cellular biology research, as they allow for the dissection of Rab 39B's role in vesicle trafficking and the broader Rab GTPase signaling network. Moreover, due to the specific role of Rab 39B in cellular vesicle dynamics, these inhibitors can serve as important tools for elucidating the molecular mechanisms underlying intracellular transport, protein trafficking, and the regulatory pathways associated with Rab GTPases.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAPK. By affecting this pathway, it could potentially lead to changes in the expression of Rab-39B. | ||||||